Concord Drugs Limited

₹72.44As of Sun 8 Nov 2026, 12:00 UTC
BSE:538965Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 1.75%
Div yield —
ROE 2.55%
Pharmaceutical Preparations
Beta (5Y) 0.66
PE TTM 42.13
TSR TTM 4.92%
Mkt cap ₹954.4M
ROIC 5.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹77
6.56%
696.47%
Hold 3|7|6|12|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.87
1.94
1.91
1.86
16.19%
16.83%
14.40%
6.28%
Revenue₹M
50.56
51.37
52.93
52.11
(1.15%)
2.56%
6.93%
0.73%
Peers (US$9.983M)
Cap (US$)
PE
9.372M
9.744x
Capital
TTM
5Y
10Y
Leveragex
0.438
0.165
0.156
EBIT/Intx
0.136
1.091
0.981
Own earn%
72.21
106.65
100.09
Sh yield%
33.43
26.61
29.57
Owners
Insiders/Inst%
6.27
63.06
Short interest%
3.71
SBC / revenue%
2.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
4–8
$1 testx
—
Incr. ROIC%
14